Rocket Pharmaceuticals Inc (RCKT)
21.91
+0.06
(+0.27%)
USD |
NASDAQ |
Apr 30, 14:27
Rocket Pharmaceuticals Free Cash Flow: -211.39M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -211.39M |
| September 30, 2023 | -236.69M |
| June 30, 2023 | -219.25M |
| March 31, 2023 | -206.16M |
| December 31, 2022 | -186.76M |
| September 30, 2022 | -160.46M |
| June 30, 2022 | -147.35M |
| March 31, 2022 | -145.44M |
| December 31, 2021 | -128.88M |
| September 30, 2021 | -123.92M |
| June 30, 2021 | -113.85M |
| March 31, 2021 | -100.24M |
| December 31, 2020 | -103.70M |
| September 30, 2020 | -104.66M |
| June 30, 2020 | -101.04M |
| March 31, 2020 | -99.26M |
| December 31, 2019 | -87.93M |
| September 30, 2019 | -80.64M |
| June 30, 2019 | -75.17M |
| Date | Value |
|---|---|
| March 31, 2019 | -60.37M |
| December 31, 2018 | -55.24M |
| September 30, 2018 | -49.02M |
| June 30, 2018 | -41.03M |
| March 31, 2018 | -33.94M |
| December 31, 2017 | -26.18M |
| September 30, 2017 | -21.98M |
| June 30, 2017 | -27.13M |
| March 31, 2017 | -32.60M |
| December 31, 2016 | -37.75M |
| September 30, 2016 | -33.60M |
| June 30, 2016 | -28.98M |
| March 31, 2016 | -24.84M |
| December 31, 2015 | -17.42M |
| September 30, 2015 | -13.37M |
| June 30, 2015 | -11.88M |
| March 31, 2015 | -9.881M |
| December 31, 2014 | -9.743M |
Free Cash Flow Range, Past 5 Years
-236.69M
Minimum
Sep 2023
-75.17M
Maximum
Jun 2019
-138.57M
Average
-123.92M
Median
Sep 2021
Free Cash Flow Benchmarks
| ADMA Biologics Inc | 3.819M |
| Geron Corp | -168.57M |
| Madrigal Pharmaceuticals Inc | -325.71M |
| Ligand Pharmaceuticals Inc | -4.272M |
| Puma Biotechnology Inc | 14.37M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.34M |
| Cash from Investing (Quarterly) | -140.80M |
| Cash from Financing (Quarterly) | 0.391M |
| Free Cash Flow Per Share (Quarterly) | -0.3637 |
| Free Cash Flow Yield | -11.49% |